A Phase I-II 24 Week Multicenter Double Blind Randomized Dose Ranging Study to Evaluate the Safety and Efficacy of a Humanized Monoclonal Antibody to PTHrP Versus Zoledronic Acid in Patients with Breast Cancer Metastatic to Bone

  • Romond, Edward (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date6/1/037/31/04